Welcome to the July edition of Digital Health Digest!Dive into this month’s highlights, including strategic partnerships, significant funding rounds, and crucial IT disruptions in healthcare. Explore how these developments are driving innovation and addressing…
Continue Reading
Dr. Sriram Rajagopalan, Head of Training & Learning Services at Inflectra From predictive analytics to personalized treatment plans, we’ve probably all heard about AI’s potential to revolutionize medical diagnostics and treatment. As discussed in…
Continue Reading
What You Should Know:
GE HealthCare (Nasdaq: GEHC) and Amazon Web Services (AWS) (Nasdaq: AMZN) announced a collaboration today, focused on developing next-generation artificial intelligence (AI) tools to transform healthcare delivery. This strategic partnership will…
Continue Reading
What You Should Know: – Pearl, the undisputed leader in dental artificial intelligence (AI) raises $58M in Series B funding led by Left Lane Capital with participation from key players like Craft Ventures and…
Continue Reading
GE HealthCare this past week said it will acquire the clinical artificial intelligence business of Intelligent Ultrasound Group. The price for the software buy is about $51 million, the companies said.WHY IT MATTERSIntelligent Ultrasound…
Continue Reading
The Queen Victoria Hospital has invested £750,000 in a CT scanner, which is aimed at improving access to diagnostics and increasing the hospital’s capacity.
The Siemens machine replaces the hospital’s first scanner, funded by the…
Truvian Health, maker of a benchtop blood testing system, announced it secured $74 million in capital and is partnering with Canada’s largest pharmacy, Shoppers Drug Mart. Great Point Ventures and Wittington Ventures co-led the round,…
Continue Reading
Introduction
Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, has made a significant move to bolster its leadership team by appointing Teri Thomas as Chief Business Officer (CBO) of its Cancer…
Introduction
Lantheus Holdings, Inc., a renowned radiopharmaceutical-focused company, has made a significant stride in the cancer care sector by acquiring the global rights to Life Molecular Imaging’s RM2. This novel therapeutic and diagnostic pair targets…
Ivor Campbell, CEO of Snedden Campbell
Anyone who works in medical technology knows that the industry is currently focused obsessively on two prime targets – maximizing the availability of self-testing and playing its part in…
Continue Reading
